Anti-158P1D7 (clone Hal5-10acl2)-vc-MMAE ADC
CAT#: ADC-040CL
This ADC product is composed of an anti-158P1D7 antibody (clone Hal5-10acl2) conjugated via vc linker to MMAE (Hal5-10acl2vcMMAE). It has demonstrated a response in Glioblastoma, Lung, Bladder, Breast cancer treatment by a MOA (Mechanism of Action) of microtubules depolymerizing.
Specifications
- Antibody Overview
- Anti-158P1D7 Hal5-10acl2. MAbs to 158P1D7 were generated using XenoMouse technology® (Amgem
Fremont) wherein the Murine Heavy and kappa Light chain loci have been inactivated and a majority of the Human Heavy and kappa Light chain immunoglobulin loci have been inserted. The MAb designated Hal5-10acl2 was generated from immunization of Human γ2 producing
XenoMice with recombinant 3T3 cells expressing 158P1D7.
- Clone
- Hal5-10acl2
- Linker
- VC (valine-citrulline)
- Linker Class/Description
- Class: Enzymatically cleavable linkers-Peptide linkers
Description: peptide linkers, belonging to Enzymatically cleavable linkers, combine greater systemic stability with rapid enzymatic release of the drug in the target cell. The scission of peptidic bonds relies on lysosomal proteolytic enzymes, which have very low activities in blood due to endogenous inhibitors and the unfavorably high pH value of blood.
- Drug
- MMAE (Monomethyl auristatin E)
- Drug Class/Description
- Class: Auristatin
Description: Auristatins are water-soluble dolastatin analogs of dolastatin 10. Dolastatin 10 belongs to dolastatin family and it can powerfully bind to tubulin, thus inhibiting polymerization mediated through the binding to the vinca alkaloid binding domain, and causes cell to accumulate in metaphase arrest.
Target
- Introduction
- 158P1D7 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in Glioblastoma, Lung, Bladder, Breast cancers.
REVIEWS AND Q&AS
CITATIONS
RESOURCES
DOWNLOADS
RELATED PRODUCTS
Inquiry
Navs
Customer Review
There are currently no Customer reviews or questions for ADC-040CL. Click the button above to contact us or submit your feedback about this product.
Submit Your Publication
Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.
Downloadable Resources
Download resources about recombinant antibody development and antibody engineering to boost your research.
Datasheet
MSDS
COA
Certificate of Analysis LookupTo download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number:
See other products for "158P1D7"
Select a product category from the dropdown menu below to view related products.
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-0347CL | Human Anti-158P1D7 Recombinant Antibody (TAB-0347CL) | FC, Inhib, FuncS | Chimeric (Mouse/Human) IgG2, κ |
| TAB-0347CL-S(P) | Mouse Anti-158P1D7 Recombinant Antibody; scFv Fragment (TAB-0347CL-S(P)) | FC, Inhib, FuncS | Mouse scFv |
| TAB-0347CL-F(E) | Human Anti-158P1D7 Recombinant Antibody; Fab Fragment (TAB-0347CL-F(E)) | FC, Inhib, FuncS | Chimeric (Mouse/Human) Fab |
Specific Inquiry
Add to compare
See Our Custom Production in Action
Popular Products
Application: WB, ELISA, IP, FC, FuncS, Neut, IF
Application: WB, FC, IP, ELISA, Neut, FuncS, IF
Application: ELISA, IP, FC, FuncS, Neut, IF, ICC
Application: Inhib, Cyt
Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
Application: FuncS, IF, Neut, ELISA, FC, IP, IHC
Application: Neut, Inhib, FC, ELISA
Application: ELISA, WB, Neut, Funcs, IHC, Inhib
Application: ELISA, IHC, FC, IP, IF, FuncS
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
